Sign in

CIK 0001665988

  • Accelerated filer
  • Emerging growth company

Bioventus Inc.

Sign in to watch
Ticker
BVS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
810980861
Phone
+1 919-474-6700
Business address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
  1. 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 7,576 shares (option exercise)
  4. 4 Open-market buy Director bought 88,000 shares at an average $2.68 ($235,567)
  5. 4 Open-market buy Interim CEO bought 125,000 shares at $2.33 ($290,988)
  6. 4 Open-market buy Director bought 1,315,673 shares at an average $1.96 ($2,573,128)
  7. 4 Planned sale Fmr. Chief Commercial Officer sold 142 shares at an average $8.81 ($1,251)
  8. 4 Planned sale SVP & Chief Compliance Officer sold 131 shares at an average $7.69 ($1,007)
  9. 4/A Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Planned sale SVP & Chief Compliance Officer sold 117 shares at $1.07 ($125)
  17. 4 Open-market sale SVP & CFO sold 6,044 shares at $1.27 ($7,676)
  18. 4 Exercise or conversion SVP & CFO acquired 18,625 shares (option exercise)
  19. 4 Open-market sale SVP & General Counsel sold 3,409 shares at $1.39 ($4,737)
  20. 4 Exercise or conversion Director acquired 3,949 shares (option exercise)

Page 8 of 13 · 251 filings